News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 21 Jul 2026 How Scientists Can Revive Global Health Drug Development Think Global Health
Scientific articles 19 Aug 2026 A serological method’s ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data The Journal of Infectious Diseases
Press releases 14 Dec 2022 Launch of first platform for emergency research preparedness and response in Africa
Press releases 1 Dec 2022 DNDi partners in a new NIHR-funded Global Health Research Group on HIV-associated Fungal Infections (IMPRINT)
Press releases 30 Nov 2022 Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Press releases 15 Nov 2022 Leishmaniasis project launched in Eastern Africa to improve patient access to treatments
Press releases 6 Oct 2022 Le Canton de Genève soutient la recherche sur le mycétome, l’une des maladies les plus négligées au monde
Press releases 29 Sep 2022 Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa
Press releases 5 Sep 2022 Dr Luis Pizarro becomes new Executive Director of the Drugs for Neglected Diseases initiative
Press releases 30 Aug 2022 Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and DNDi to explore joint opportunities to develop affordable and life-saving new drugs for neglected tropical diseases
Press releases 3 Aug 2022 Network of experts calls for urgent boost to research and development of rapid tests for cutaneous leishmaniasis in Latin America
Press releases 27 Jul 2022 Korean cutting-edge technology to reduce the cost of promising drug for neglected disease visceral leishmaniasis
Press releases 6 Jul 2022 Wellcome renews partnership with DNDi to develop new generation drugs to treat leishmaniasis
Press releases 5 Jul 2022 Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19
Press releases 29 Jun 2022 DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas
Press releases 14 Jun 2022 Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
Press releases 8 Jun 2022 New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV
Press releases 1 Jun 2022 Thai partners unite with DNDi to improve access to treatments and diagnostics for people with hepatitis C in Thailand
